Latest filings (excl ownership)
8-K
IMUNON Reports Compliance with Nasdaq Listing Requirements
11 Apr 24
RW
Registration withdrawal request
10 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
IMUNON Reports 2023 Financial Results and Provides Business Update
28 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
18 Mar 24
8-K
IMUNON Announces Leadership Change
12 Mar 24
S-1/A
IPO registration (amended)
9 Feb 24
S-1/A
IPO registration (amended)
17 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Dec 23
S-1
IPO registration
20 Dec 23
8-K
Departure of Directors or Certain Officers
11 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
14 Nov 23
S-8
Registration of securities for employees
11 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update
10 Aug 23
8-K
Departure of Directors or Certain Officers
15 Jun 23
8-K
Departure of Directors or Certain Officers
14 Jun 23
UPLOAD
Letter from SEC
26 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
IMUNON Reports First Quarter 2023 Financial Results and Provides Business Update
11 May 23
CORRESP
Correspondence with SEC
5 May 23
UPLOAD
Letter from SEC
3 May 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
IMUNON Reports 2022 Financial Results and Provides Business Update
30 Mar 23
8-K
Amendments to Articles of Incorporation or Bylaws
24 Mar 23
8-K
Departure of Directors or Certain Officers
10 Feb 23
8-K
Departure of Directors or Certain Officers
3 Jan 23
8-K
Third Quarter 2022 Conference Call
15 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
IMUNON Reports Third Quarter 2022 Financial Results
14 Nov 22
8-K
Imunon Appoints James E. Dentzer to its Board of Directors
3 Oct 22
8-K
New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines
19 Sep 22
S-8
Registration of securities for employees
15 Aug 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K
Celsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update
15 Aug 22
8-K
Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer
19 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 22
Latest ownership filings
4
JEFFREY WAYNE CHURCH
18 Mar 24
4
Khursheed Anwer
18 Mar 24
4
Michael H Tardugno
18 Mar 24
4
Frederick J. Fritz
18 Mar 24
4
Donald P Braun
18 Mar 24
4
Christine A Pellizzari
18 Mar 24
4
Stacy Lindborg
18 Mar 24
4
James E Dentzer
18 Mar 24
4
Sebastien Hazard
11 Dec 23
3
Sebastien Hazard
11 Dec 23
4
Donald P Braun
21 Mar 23
4
Pok Yu Augustine Chow
21 Mar 23
4
Frederick J. Fritz
21 Mar 23
4
Christine A Pellizzari
21 Mar 23
4
James E Dentzer
21 Mar 23
4
Stacy Lindborg
21 Mar 23
4
Michael H Tardugno
21 Mar 23
4
Khursheed Anwer
21 Mar 23
4
JEFFREY WAYNE CHURCH
21 Mar 23
4
Goff Corinne Le
21 Mar 23
4
James E Dentzer
3 Oct 22
3
James E Dentzer
3 Oct 22
4
Goff Corinne Le
20 Jul 22
3
Goff Corinne Le
20 Jul 22
4
Constantine John Kardaras
15 Jun 22
4
Timothy J Tumminello
15 Jun 22
4
Pok Yu Augustine Chow
15 Jun 22
4
Frederick J. Fritz
15 Jun 22
4
Robert W Hooper
15 Jun 22
4
Stacy Lindborg
15 Jun 22
4
Christine A Pellizzari
15 Jun 22
4
Donald P Braun
15 Jun 22
4
JEFFREY WAYNE CHURCH
15 Jun 22
4
Michael H Tardugno
15 Jun 22
4
Michael H Tardugno
12 Apr 22
4
Frederick J. Fritz
11 Apr 22
4
Timothy J Tumminello
7 Mar 22
4
Constantine John Kardaras
7 Mar 22
4
Michael H Tardugno
7 Mar 22
4
Donald P Braun
7 Mar 22